Incorrect, no news is bad news.This share is expensive. Brokers think so and so do retailers. We need clarity rather than false hope.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025